REFERENCES
- Hellewell PG, Williams TJ. (Hs) Immunopharmacology of neutrophils. Academic Press. London, San Diego, New York, 1994.
- Van den Broek PJ. Antimicrobial drugs, microorganisms, and phagocytes. Rev Infect Dis 1989; 11: 213–45.
- Labro MT. Interference of antibacterial agents with phagocyte functions: immunomodulation or «immuno-fairyo tales. Clin Microbiol Rev 2000; 13: 615–650.
- Labro MT. Antiinflammatory activity of macrolides. A new therapeutic potential? J Antimicrob Chemother 1998; 41 (Suppl. B): 39-46.
- Labro MT. Immunological effects of macrolides. Curr Op Infect Dis 1998; 11: 681–688.
- Labro MT, El Senna J, Babin-Chevaye C. Comparison of the in vitro effect of several macrolides on the oxidative burst of human neutrophils. J Antimicrob Chemother 1989; 24: 561–572.
- Abdelghaffar H, Vazifeh D, Labro MT. Erythromycin A-derived macrolides modify the functional activities of human neutrophils by altering the phospholipase D-phosphatidate phosphohydrolase transduction pathway. J Immunol 1997; 159: 3995–4005.
- Anderson R. Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoat-tractant-derived superoxide generation and auto-oxidation. J Infect Dis 1989; 159: 966–973.
- Laufen H, Wildfeuer A, Lach P. Mechanism of azithromycin uptake in human leucocytes. Arzneim Forschung 1990; 40: 686–689.
- Vazifeh D, Abdelghaffar H, Labro MT. Cellular accumu-lation of the new ketolide RU 64004 by human neutrophils: comparison with that of azithromycin and roxithromycin. Antimicrob Agents Chemother 1997; 41: 2099-2107.
- Vazifeh D, Preira A, Bryskier A, Labro MT. Interactions between HMR 3647, a new ketolide, and human polymor-phonuclear neutrophils. Antimicrob Agents Chemother 1998; 42: 1944-1951.
- Labro MT, El Benna J, Abdelghaffar H. Modulation of human polymorphonuclear neutrophil function by macrolides: preliminary data concerning dirithromycin. J Antimicrob Chemother 1993; 31 (Suppl. C): 51-64.
- Tucker KA, Lilly MB, Heck L, Rado TA. Characterization of a new human diploid myeloid leukemia cell line (PLB-985) with granulocytic and monocytic differentiating capacity. Blood 1987; 70: 372–378.
- Pedruzzi E, Fay M, Gaudry M, Gougerot-Pocidalo MA. Differentiation of PLB-985 myeloid cells into mature neu-trophils, shown by degranulation of terminally differentiated compartments in response to N-formyl peptide and priming of superoxide anion production by granulocyte-macrophage colony-stimulating factor. Br J Haematol 2002; 117: 719–726.
- Abdelghaffar H, Vazifeh D, Labro MT. Cellular uptake of two fluoroketolides, HMR 3562 and HMR 3787, by human polymorphonuclear neutrophils in vitro. Antimicrob Agents Chemother 2001; 45: 2798-2806.
- Miossec-Bartoli C, Pilatre L, Peyron P, et al. The new ketolide HMR 3647 accumulates in the azurophilic granules of human polymorphonuclear cells. Antimicrob Agents Chemother 1999; 43: 2457-2462.
- Vazifeh D, Bryskier A, Labro MT. Effect of proinflam-matory cytokines on the interplay between roxithromycin, HMR 3647 or HMR 3004 and polymorphonuclear neu-trophils. Antimicrob Agents Chemother 2000; 44: 511–521.
- Vazifeh D, Labro MT. Investigation of the uptake of HMR 3647, HMR 3004 and roxithromycin by myelomono-cytic cell lines. In Program and Abstracts of the 39th ICAAC, September 26-29, San Francisco, ASM Press Washington DC, 1999 Abstr. 1929, p. 48.
- Nibbering PH., Zomerdijk TP, Corsel-Van Tilburg AJ, Van Furth R. Mean cell volume of human blood leucocytes and resident and activated murine macrophages. Immunol Meth 1990; 129: 143–145.
- Levert H, Gressier B, Moutard I et al. Azithromycin impact on neutrophil oxidative metabolism depends on expo-sure time. Inflammation 1998; 22: 191–201.
- Abdelghaffar H, Bryskier A, Labro MT. Effect of RU 004 on oxidant production by human neutrophils In Program and Abstracts of the 36th ICAAC, September 15-18 New Orleans, ASM Press Washington DC, 1996 Abstr. F-225, p. 139.